Navigation Links
Immunosyn Corporation Announces 2007 Results, Files 10KSB
Date:3/31/2008

LA JOLLA, Calif., March 31 /PRNewswire-FirstCall/ -- Immunosyn Corporation (OTC Bulletin Board: IMYN), a biotechnology firm that has obtained exclusive worldwide marketing, sales and distribution rights to the biopharmaceutical SF-1019, has announced its results for the fiscal year ending December 31, 2007.

For the year ended December 31, 2007, the company incurred $647,000 in general and administrative expenses and $26,000 in interest expense which was funded from advances by affiliates of $641,000, accounts payable of $152,000 and accrued expenses of $17,000. As a result, the company had a Net Loss of $672,837 for the 2007 fiscal year. From the company's inception on August 3, 2006 until December 31, 2006, the company incurred $156,000 in general and administrative expenses and no interest expense and had a net loss of $156,000 for such period. Immunosyn has had no revenue to date as Argyll Biotechnologies, LLC is still in the process of obtaining governmental and regulatory approval for SF-1019.

"We were able to significantly control costs in 2007 and appreciated the advances from affiliates," noted Stephen Ferrone, Immunosyn's CEO. "In 2008, Argyll Biotechnologies, LLC has reported positive research results for SF-1019 and Immunosyn hopes to add shareholder value by striving for financial efficiency in the execution of its marketing and distribution strategy when approvals for SF-1019 are obtained by Argyll Biotechnologies, LLC," added Ferrone.

Research suggests that SF-1019 has analgesic properties with a perceived ability to reduce the inflammation present in a number of clinical conditions including Multiple Sclerosis (MS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Reflex Sympathetic Dystrophy Syndrome, (RSD or RSDS) and other auto-immune and neurological disorders. A recent, limited proof of concept trial for SF-1019 in Europe has shown positive results in effectively treating diabetic ulcers. Immunosyn went public
'/>"/>

SOURCE Immunosyn Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Immunosyn Corporation to Present at FSX
2. Immunosyn Corporation Names G. David Criner as CFO
3. WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation
4. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News
5. USANAs CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporations Board of Directors
6. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
7. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
10. BioElectronics Corporation Announces Singapore and Malaysia Sales
11. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...ected to aid drug discovery by allowing for the ra...gle reaction, ST. LOUIS, Oct. 7 /PRNewswire-First...o announce that it has signed an exclusive licensi...bana-Champaign allowing,Sigma-Aldrich to offer res...ogates for use in Suzuki-Miyaura coupling to resea...
(Date:10/7/2008)...s to focus on new patient data supporting the Ross...ynerGraft processed human heart .../- CryoLife, Inc. (NYSE: C...ocessing company, announced today,that cardiovascu...e in the,Ross Summit 2008, a two-day surgical cong...
(Date:10/7/2008)...Institutes of Health, The Infectious Disease Resea...Launch and Board of Advisors, SEATTLE, Oct. 7 /PR...,Initiative today announced its first acquisition ...osis (TB) drug candidates. Agreements were reached...nd the Microbial Chemistry,Research Foundation (MC...
(Date:10/7/2008)... Oct. 7 /- BioEnergy International, L...r and manufacturer of,next-generation, renewable b...f Norman R. Augustine to its Board of Advisors eff...f distinguished leadership and innovation,at the h...g in his role as,Chairman and Chief Executive Offi...
Breaking Biology Technology:Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 2Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 2CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 2Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 3Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 5BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3
...Inc. a provider of supply chain execution (SCE) ...rove supplier compliance and inbound productivity ... Internet. CatalystConnect Supplier Link and Cata...sed solutions suite, Supplier Link supports OAG (O...e system can be easily integrated with any warehou...
...technology that will be used to discover why patie...ond to medication and to identify the causes of an...ganisms. Wisconsin- based OpGen, has announced the...em for rapid, cost-effective analysis of whole gen... powerful tool for high-resolution genome-wide ana...
...d academic leaders in the biotech and life science...ed Wednesday in Chicago as part of the JETRO Midwe...ed similarity of challenges faced by Midwest Biot... goal was to foster discussion and lay down specif...&D throughout the widest in collaboration with Jap...
...e Bust, Now the Third Incarnation ,Featuring Bob T...st to Address Madison Business, Technology Leaders...tcom and Technology Future. , ,Bob Tedeschi,s infl...in the Monday Business section of The New York Tim...ll deliver an original, uniquely informative and e...
Other Biology Technology:Software Enables Suppler Customer Data Integration 2Whole Genomes From Microbes to Man 2Whole Genomes From Microbes to Man 3Japan, Midwest Biotechnology Industry Leaders Identify Steps for Greater Collaboration Between Countries 2
(Date:10/6/2008)... of Health has awarded $4 million to a group of Ph...lth & Science University to aid in the discovery o...e mollusks for development in the Philippines., T...ilippine archipelago whose waters are inhabited by...out a fifth of all the known species, and are rega...
(Date:10/6/2008)...hers have developed a new prenatal blood test that...erious chromosomal defects in a small study of 18 ...y say, the test would offer a safer and faster alt...entesis that pose a small risk of miscarriage., R... blood contains small amounts of DNA from the fetu...
(Date:10/6/2008)...arch study funded by JDRF suggests that a common i...m developing type 1 diabetes. The findings provide...hy type 1 diabetes develops in people, and may lea...s week in Nature Magazine, lends further support...appropriate amount and composition of bacteria may...
(Date:10/6/2008)...aboratory (CSHL) is clarifying a previously unappr...in cancer. , Last year, scientists from the sam...lled SF2/ASF--a protein that changes the instructi...ce tumors in cell cultures. The team,s newly publi...rstood, this same splicing factor acts on a group ...
Breaking Biology News(10 mins):Discovering drugs, biofuels in tropical seas 2Discovering drugs, biofuels in tropical seas 3Discovering drugs, biofuels in tropical seas 4New blood test for Down syndrome 2New blood test for Down syndrome 3New blood test for Down syndrome 4JDRF funded study links 'hygiene hypothesis' to diabetes prevention 2Cold Spring Harbor Laboratory scientists trace a novel way cells are disrupted in cancer 2Nolo com Adds Up the Emotional Costs of Foreclosure With the Five Stages of Foreclosure Grief 17066 1Nolo com Adds Up the Emotional Costs of Foreclosure With the Five Stages of Foreclosure Grief 17066 2Nolo com Adds Up the Emotional Costs of Foreclosure With the Five Stages of Foreclosure Grief 17066 3ProGenTech Limited Appoints Executive Management Team 17063 1ProGenTech Limited Appoints Executive Management Team 17063 2New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks 2934 1New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks 2934 2The Leukemia 26 Lymphoma Society and Anjin Group Announce Multi Year Collaborative Research Agreement 1834 1The Leukemia 26 Lymphoma Society and Anjin Group Announce Multi Year Collaborative Research Agreement 1834 2The Leukemia 26 Lymphoma Society and Anjin Group Announce Multi Year Collaborative Research Agreement 1834 3
...ransplants of embryonic stem cell-derived motor ne...nd partially restore function in paralyzed animals...e useful for treating such disorders as spinal cor... sclerosis (ALS), and spinal muscular atrophy. The...stitute of Neurological Disorders and Stroke (NIND...
...ales, behaviour during their long, deep dives, tha...tags". According to new research published in the ...logy, sperm whales ?like bats ?use echolocation co...Working in the Atlantic, the Gulf of Mexico and th...raphic Institution and the University of St Andrew...
...he catastrophic effect of a deadly virus on Britai...at squirrel poxvirus is threatening to wipe out re...ain in northern England within 10 years. In areas...cline in reds is 17-25 times higher than in places...he reds, main survival challenge was believed to b...
...ery much greater rate of chromosomal abnormalities...ntist told the 22nd annual conference of the Europ...n Prague, Czech Republic on Wednesday 21 June 2006...of Obstetrics and Gynaecology, Chulalongkorn Unive... to be aware of this problem and monitor carefully...
Other Biology News:Neurons grown from embryonic stem cells restore function in paralyzed rats 2Neurons grown from embryonic stem cells restore function in paralyzed rats 3Neurons grown from embryonic stem cells restore function in paralyzed rats 4Ecologists home in on how sperm whales find their prey 2Virus has 'catastrophic' affect on red squirrels, research shows 2Virus has 'catastrophic' affect on red squirrels, research shows 3Chromosomal abnormalities in sperm higher after vasectomy reversal 2
Polyclonal Antibody to Coronin / CORO1C This antibody was developed against synthetic peptides corresponding to amino acids 407-420 of human CORO1C.
Mouse Wnt-9b Biotinylated Affinity Purified PAb ENTREZ GeneID: 22412
Homo sapiens MEP50 protein, mRNA
SeeDNA co-precipitant, 250 ul (125 precipitations). Vivid pink color ensures easy pellet location.Efficient precipitation maximizes nucleic acid recovery.Chemically inert, compatible with most molecu
Biology Products: